Efficacy and safety of adding sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline BMI ≥27 kg/m<sup>2</sup>
| Image |  |
|---|---|
| Description | scientific article published on 02 December 2020 |
| Author/s |
author: Juan Frias Francisco Javier Ampudia Blasco Thomas Danne |
| Publication date | December 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |